Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 4/20 | 0.54 |
| ▸ | KIF11 | P52732 | 5/20 | 0.53 |
| ▸ | MDM4 | O15151 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 3/20 | 0.53 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6273699 | 1.00 | MDM2 (0.54) | MDM2KIF11MDM4TP53SLC17A5 | |
| SCHEMBL21639223 | 1.00 | MDM2 (0.54) | MDM2KIF11MDM4TP53SLC17A5 | |
| SCHEMBL29400885 | 1.00 | MDM2 (0.54) | MDM2KIF11MDM4TP53SLC17A5 | |
| SCHEMBL29395463 | 0.92 | MDM4 (0.55) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL29560536 | 0.92 | MDM4 (0.55) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL1738641 | 0.92 | MDM4 (0.55) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL5998507 | 0.92 | MDM4 (0.55) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL3436122 | 0.92 | MDM4 (0.55) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL29503847 | 0.92 | MDM4 (0.55) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL12127262 | 0.92 | KIF11 (0.51) | MDM2KIF11MDM4TP53CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-115490756-A | Method for preparing eptifibatide by solid-liquid phase combination | 深圳市健翔生物制药有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-112062811-B | Synthetic method of vilacatide | 深圳翰宇药业股份有限公司 | 2022-03-25 | — | — | CN | disclosed |